TP53 and breast carcinoma: Cancer cells with different missense mutations of the TP53 gene (Table 1) had the endogenous level of ROS significantly higher than cells with wild-type TP53 alleles in both pancreatic and breast cancer cell lines (Supplementary Figure 1), suggesting a possible involvement of mutant p53 in the production of ROS.